Delivery Order SPE2DB20D3505-SPE2DB25FYBWF
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,040.97 for epinephrine 0.3 mg auto-injector pens (two-pack) on August 8, 2025, with completion scheduled for August 11, 2025. This competitively awarded, firm fixed-price contract represents a pediatric or emergency medical supply procurement supporting federal healthcare systems. The contract is not set-aside and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,921.97 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-inject pens (2-pack) with an ultimate completion date of August 18, 2025. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The place of performance is listed as the company's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a $1,291.54 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Epinephrine 0.3 mg auto-injector pens (2-pack). This firm fixed-price delivery order, with an ultimate completion date of July 24, 2025, represents a pediatric and emergency medical supply critical for military and federal healthcare systems. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,029.14 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector pens (2-pack units). This firm fixed price, non-set-aside delivery order was awarded on July 30, 2025, with an ultimate completion date of July 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $7,610.35 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector pens (2-pack) on August 15, 2025, with an ultimate completion date of August 18, 2025. The contract is a firm fixed price delivery order with no set-aside designation, performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award represents a competitive procurement under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, valued at $1,595.49. This is a firm fixed price delivery order with an ultimate completion date of August 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,590.55 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector pens (2-packs) on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed-price contract, which carries no set-aside designation, was competitively awarded and will be performed at the contractor's Conshohocken, Pennsylvania facility. The delivery order represents a small-value transaction under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $13,905.12 to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Epinephrine 0.3 mg auto-injector units (two-pack configuration). This firm fixed-price delivery order is scheduled for ultimate completion on August 4, 2025, and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, demonstrating...
- The Defense Logistics Agency awarded a delivery order valued at $15,095.42 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector 2-packs. This firm fixed-price delivery order, issued on July 30, 2025, represents a competitively awarded contract with no set-aside designation and is scheduled for completion by July 31, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order valued at $16,773.49 to AmerisourceBergen Drug Corp for the supply of epinephrine 0.3 mg auto-inject pens (2-count packages). This firm fixed-price contract, awarded on August 25, 2025, with completion targeted for August 26, 2025, represents a small-value transaction under the company's larger pharmaceutical supply agreement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB25FYBWFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,890.21 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector pens (2-pack units). This competitively awarded, firm fixed-price delivery order was issued on August 22, 2025, with an ultimate completion date of August 25, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a non-set-aside award, this order was competed among qualified federal vendors and reflects the agency's standard procurement process for medical supplies. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. This comprehensive pharmaceutical prime vendor contract enables AmerisourceBergen to supply critical medical commodities, including specialty medications, brand-name and generic drugs, vaccines, and medical devices to support military healthcare programs globally. The arrangement allows the company to serve the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, with DLA planning future iterations of the Pharmaceutical Prime Vendor Global Program that may involve multiple regional awards across different contractors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 8/22/25 |